Acorn is a developer of cloud-based analytic clinical research solutions. TrialCTA, Acorn Applications' lead product, is a cloud-based Software-as-a-Service (SaaS) application that helps CROs, medical device and pharmaceutical companies manage and track complex global clinical trial contracts. The application combines an intuitive workflow with a flexible rules engine to manage, track and accelerate clinical research study site contracts. In addition, TrialCTA has built-in integration capability with any external system including Document Management, EDC, CTMS or IVR, allowing incorporation of contract negotiation data into the overall clinical trial site initiation process.
"We chose TrialCTA because it is the only system on the market specifically designed for the Clinical Trial Agreement (CTA) lifecycle, which greatly enhances our global service offering," said Brandon Evans, CEO of Clintrax Global. "This system enables us to provide real-time, accurate reporting and transparency to our clients. TrialCTA is fully customizable, giving us the ability to cater to the different tracking and reporting needs for each client. More importantly, its flexible notification system ensures that no agreement is lost or neglected."
Gordon Jones, CEO of Acorn Applications, said, " Study sponsors are demanding real-time transparency and faster study startup, so we designed TrialCTA from the ground up to specifically meet the tracking needs of Clinical Trial Agreements."